Stocksigma LogoStocksigma Logo

Bal Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 8,995 (+21.5% YoY | +1.5% QoQ) ■ EBITDA: 866 (+51.2% YoY | +9.0% QoQ) ■ EBITDA Margin (%): 9.6 (+189 bps YoY | +66 bps QoQ) ■ PAT: 142 (+99.9%

Bal Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Bal Pharma Ltd · Financial Result · 11 Nov 2026, 11:41 pm

Bal Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 8,995 (+21.5% YoY | +1.5% QoQ) ■ EBITDA: 866 (+51.2% YoY | +9.0% QoQ) ■ EBITDA Margin (%): 9.6 (+189 bps YoY | +66 bps QoQ) ■ PAT: 142 (+99.9% YoY | +26.3% QoQ) ■ EPS (INR): 0.89 (+97.8% YoY | +25.4% QoQ)

Original exchange filing (PDF)

More announcements from Bal Pharma Ltd

All Bal Pharma Ltd announcements